![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project
The latest European Guidelines of Arterial Hypertension have officially introduced uric acid evaluation among the cardiovascular risk factors that should be evaluated in order to stratify patient’s risk. In fa...
-
Article
3.10 Assessment of Pulse Wave Velocity and Cardiovascular Risk Stratification in a General Population: the Vobarno Study
-
Article
12.18 Correlation between Ambulatory Arterial Stiffness Index (AASI) and Pulse Wave Velocity in a General Population: the Vobarno Study
-
Article
1.7 Carotid Intima-Media Thickness and Prevalence of Plaques in Patients with Primary Aldosteronism and With Essential Hypertension
-
Article
12.15 Effect of Anti-Hypertensive Treatment on Circulating Endothelial Progenitor Cells in Patients with Mild Essential Hypertension
-
Article
12.19 Evidence of a Relationship between Arterial Stiffness and Microcirculation in Hypertensive Patients
-
Article
2.8 In Patients with Isolated Ambulatory Hypertension Central Blood Pressure and Augmentation Index are Increased: the VOBARNO Study
-
Article
4.26 Left Ventricular Mass Appropriateness in Patients with Primary Aldosteronism
-
Article
1.14 Arterial Stiffness in Patients with Sustained, Isolated Clinical and Ambulatory Hypertension: the Vobarno Study
-
Article
4.25 EKG Left Ventricular Hypertrophy and Risk of Cardiovascular Events in Patients with Type 1 and Type 2 Diabetes Mellitus